» Authors » L Dangoumau

L Dangoumau

Explore the profile of L Dangoumau including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 57
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Carrat F, Flahault A, Boussard E, Farran N, Dangoumau L, Valleron A
J Epidemiol Community Health . 1998 Oct; 52 Suppl 1:32S-38S. PMID: 9764269
Study Objectives: To discover if continuous computerised collection of morbidity data through a medical practice based sentinel network can be used to monitor influenza-like illness (ILI) epidemics. To obtain rough...
2.
Maudhuit C, PREVOT E, Dangoumau L, MARTIN P, Hamon M, Adrien J
Psychopharmacology (Berl) . 1997 Apr; 130(3):269-75. PMID: 9151362
Chronic treatment with antidepressants renders serotonergic neuronal firing less sensitive to the inhibitory effect of serotonin (5-HT) reuptake blockers in the rat, and this has been considered as a major...
3.
Charrier D, Dangoumau L, Puech A, Hamon M, Thiebot M
Psychopharmacology (Berl) . 1995 Sep; 121(1):127-34. PMID: 8539337
The effects of cholecystokinin (CCK) receptor ligands were studied in the rat safety signal withdrawal conflict procedure, an operant paradigm sensitive to both anxiolytic and anxiogenic compounds. In this procedure,...
4.
Charrier D, Dangoumau L, Hamon M, Puech A, Thiebot M
Pharmacol Biochem Behav . 1994 May; 48(1):281-9. PMID: 7913228
The present study evaluated in the rat the ability of various 5-HT1A receptor agonists to exert an "anxiolytic-like" release of the suppression of lever pressing for food induced by the...
5.
Thiebot M, Dangoumau L, Richard G, Puech A
Psychopharmacology (Berl) . 1991 Jan; 103(3):415-24. PMID: 1676183
A new method involving the blockade of operant behaviour induced by the withdrawal of a conditioned signal for safety without presentation of a punishment signal has been developed for studying...
6.
Poncelet M, Dangoumau L, Soubrie P, Simon P
Psychopharmacology (Berl) . 1987 Jan; 92(3):393-7. PMID: 2888149
Rats with a history of daily (21 days) amphetamine (2.5 mg/kg) treatment showed enhanced activity when under placebo in their amphetamine-associated environment. We found that this conditioned effect was reduced...